GB9503850D0 - Medicaments - Google Patents

Medicaments

Info

Publication number: GB9503850D0
Authority: GB; United Kingdom
Prior art keywords: medicaments
Prior art date: 1995-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GBGB9503850.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-25

Filing date

1995-02-25

Publication date

1995-04-19

1995-02-25 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1995-02-25 Priority to GBGB9503850.1A priority Critical patent/GB9503850D0/en

1995-04-19 Publication of GB9503850D0 publication Critical patent/GB9503850D0/en

1996-02-22 Priority to JP8525996A priority patent/JPH11501303A/en

1996-02-22 Priority to PCT/EP1996/000736 priority patent/WO1996026734A1/en

1996-02-22 Priority to EP96904846A priority patent/EP0810873A1/en

1996-02-22 Priority to AU48794/96A priority patent/AU4879496A/en

1996-02-22 Priority to CA002213621A priority patent/CA2213621A1/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB9503850.1A 1995-02-25 1995-02-25 Medicaments Pending GB9503850D0 (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GBGB9503850.1A GB9503850D0 (en)	1995-02-25	1995-02-25	Medicaments
JP8525996A JPH11501303A (en)	1995-02-25	1996-02-22	Combination of antiviral agent consisting of BCH-189 and ritona beer
PCT/EP1996/000736 WO1996026734A1 (en)	1995-02-25	1996-02-22	Antiviral combinations of bch-189 and ritonavir
EP96904846A EP0810873A1 (en)	1995-02-25	1996-02-22	Antiviral combinations of bch-189 and ritonavir
AU48794/96A AU4879496A (en)	1995-02-25	1996-02-22	Antiviral combinations of bch-189 and ritonavir
CA002213621A CA2213621A1 (en)	1995-02-25	1996-02-22	Antiviral combinations of bch-189 and ritonavir

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9503850.1A GB9503850D0 (en)	1995-02-25	1995-02-25	Medicaments

Publications (1)

Publication Number	Publication Date
GB9503850D0 true GB9503850D0 (en)	1995-04-19

Family

ID=10770279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9503850.1A Pending GB9503850D0 (en)	1995-02-25	1995-02-25	Medicaments

Country Status (6)

Country	Link
EP (1)	EP0810873A1 (en)
JP (1)	JPH11501303A (en)
AU (1)	AU4879496A (en)
CA (1)	CA2213621A1 (en)
GB (1)	GB9503850D0 (en)
WO (1)	WO1996026734A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0938321B1 (en)	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
FR2779653B1 (en) *	1998-06-11	2002-12-20	Inst Nat Sante Rech Med	USE OF PROTEASOME MODULATING COMPOUNDS IN THERAPY
FR2878747B1 (en) *	2004-12-03	2007-03-30	Pierre Fabre Medicament Sa	USE OF OMEGA-3 FATTY ACID (S) FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA CAUSED BY ANTI-RETROVIRAL TREATMENT IN HIV INFECTED PATIENTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992010496A1 (en) *	1990-12-05	1992-06-25	University Of Georgia Research Foundation, Inc.	ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
ATE131730T1 (en) *	1991-05-16	1996-01-15	Glaxo Group Ltd	ANTI-VIRUS PREPARATIONS CONTAINING NUCLEOSIDE ANALOGUES
EP0639971B1 (en) *	1992-05-13	1999-09-22	The Wellcome Foundation Limited	Therapeutic combinations
GB9215178D0 (en) *	1992-07-16	1992-08-26	Glaxo Group Ltd	Antiviral combinations
UA49803C2 (en) *	1994-06-03	2002-10-15	Дж.Д. Сьорль Енд Ко	METHOD FOR TREATMENT OF RETROVIRAL INFECTIONS

1995
- 1995-02-25 GB GBGB9503850.1A patent/GB9503850D0/en active Pending
1996
- 1996-02-22 EP EP96904846A patent/EP0810873A1/en not_active Withdrawn
- 1996-02-22 AU AU48794/96A patent/AU4879496A/en not_active Abandoned
- 1996-02-22 WO PCT/EP1996/000736 patent/WO1996026734A1/en not_active Ceased
- 1996-02-22 CA CA002213621A patent/CA2213621A1/en not_active Abandoned
- 1996-02-22 JP JP8525996A patent/JPH11501303A/en active Pending

Also Published As

Publication number	Publication date
EP0810873A1 (en)	1997-12-10
CA2213621A1 (en)	1996-09-06
AU4879496A (en)	1996-09-18
JPH11501303A (en)	1999-02-02
WO1996026734A1 (en)	1996-09-06

Publication	Publication Date	Title
HUP9801151A3 (en)	2000-06-28	Long-shelf-life medicaments
ZA966969B (en)	1997-03-24	Medicaments
AP9700951A0 (en)	1997-04-30	Medicaments
GB9406573D0 (en)	1994-05-25	Medicaments
GB9420784D0 (en)	1994-11-30	Medicaments
GB9526392D0 (en)	1996-02-21	Medicaments
GB9503850D0 (en)	1995-04-19	Medicaments
GB9418530D0 (en)	1994-11-02	Medicaments
GB9421133D0 (en)	1994-12-07	Medicaments
GB9416365D0 (en)	1994-10-05	Medicaments
GB9411052D0 (en)	1994-07-20	Medicaments
EP0790829A4 (en)	2001-08-08	Medicaments
GB9519029D0 (en)	1995-11-15	Medicaments
GB9519021D0 (en)	1995-11-15	Medicaments
GB9506122D0 (en)	1995-05-10	Medicaments
GB9515628D0 (en)	1995-09-27	Medicaments
GB9517021D0 (en)	1995-10-25	Medicaments
IL127776A0 (en)	1999-10-28	Medicaments
GB9519585D0 (en)	1995-11-29	Medicaments
GB9514723D0 (en)	1995-09-20	Medicaments
GB9524173D0 (en)	1996-01-24	Medicaments
GB9521208D0 (en)	1995-12-20	Medicaments
GB9523453D0 (en)	1996-01-17	Medicaments
GB9504153D0 (en)	1995-04-19	Medicaments
GB9424013D0 (en)	1995-01-18	Medicaments